European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives
Today, Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial fermentation announce a successful fundraising from private investors including Oskare Capital and Canopy Growth Cooperation (“Canopy Growth”) former CEO and founder Bruce Linton. Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange (TSX), included on a major stock index (S&P/TSX Composite Index) and to list on the New York Stock Exchange.
“We’re thrilled to have the backing of a pioneer in the cannabis industry” says Nethaji Gallage, CEO of Octarine. “Bruce’s expertise, network, and knowledge will be a valuable asset to us, and we look forward to accelerating our technology with his and our other private investors’ support”.
“Octarine is a promising young company with a platform technology that can accelerate several rapidly evolving sectors, including work on synthesizing rare and novel cannabinoids” says Bruce Linton. “I look forward to supporting the Company and seeing their technology utilized in the market”.
The new funds will be used to strengthen the Company’s existing intellectual property and to demonstrate the commercial scalability of its fermentation-based production platform. Octarineis currently raising a seed round expected to close in early 2020.
Octarine’s mission is harnessing synthetic biology to develop rare and functionally superior cannabinoids and psilocybin derivatives targeting the pharmaceutical industry to improve the health and well-being of people worldwide. Octarine has developed in-cell enzymatic platforms expanding the chemical diversity of cannabinoids and psychedelic tryptamine derivatives facilitating the production of superior molecules with improved pharmacokinetic properties.
For more information visit www.octarinebio.com
About Bruce Linton
Mr. Linton is the founder and former CEO of Canopy Growth and co-founder of Tweed Marijuana Incorporated. Under Mr. Linton's leadership, Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange. Mr. Linton held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp., and part of the establishing team at CrossKeys Systems Corporation ("CrossKeys"). He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-ZYNGA5.8.2020 22:08:10 CEST | Press release
Zynga Enters Into Agreement to Acquire Istanbul-based Rollic, One of the Fastest Growing Hyper-Casual Mobile Game Companies
CA-ZYNGA5.8.2020 22:07:09 CEST | Press release
Zynga Announces Second Quarter 2020 Financial Results
NV-RIMINI-STREET5.8.2020 22:07:09 CEST | Press release
Rimini Street Announces Fiscal Second Quarter 2020 Financial Results
NV-RIMINI-STREET,-INC.5.8.2020 19:02:05 CEST | Press release
Rimini Street Further Speeds Software Issue Resolution with Shortened Guaranteed Response Times
CA-VERIMATRIX5.8.2020 17:37:13 CEST | Press release
Verimatrix Debuts Industry’s First Elastic Anti-Tamper Technology to Protect Bitcode-Enabled iOS Apps
NY-MOODY’S-ANALYTICS5.8.2020 17:02:12 CEST | Press release
RDC Wins Award in Celent KYC Report
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom